Gross Margin - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98% Market Closed
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

Gross Margin
MaxCyte Inc

88.4%
Current
88%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
88.4%
=
Gross Profit
40.2m
/
Revenue
45.4m

Gross Margin Across Competitors

Country US
Market Cap 425.6m USD
Gross Margin
88%
Country US
Market Cap 1.4T USD
Gross Margin
55%
Country US
Market Cap 232.4B USD
Gross Margin
41%
Country US
Market Cap 196.9B USD
Gross Margin
59%
Country KR
Market Cap 70.5T KRW
Gross Margin
50%
Country CH
Market Cap 38.5B CHF
Gross Margin
29%
Country US
Market Cap 44.7B USD
Gross Margin
35%
Country US
Market Cap 39.7B USD
Gross Margin
55%
Country US
Market Cap 29.8B USD
Gross Margin
59%
Country IE
Market Cap 25.3B USD
Gross Margin
30%
Country US
Market Cap 22.6B USD
Gross Margin
36%

Profitability Report

View the profitability report to see the full profitability analysis for MaxCyte Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
88.4%
=
Gross Profit
40.2m
/
Revenue
45.4m
What is the Gross Margin of MaxCyte Inc?

Based on MaxCyte Inc's most recent financial statements, the company has Gross Margin of 88.4%.